Inactive Instrument

Cornerstone Therapeutics, Inc. Stock

Stocks

End-of-day quote Nasdaq Other stock markets
- ^USD	-

14-02-28	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Inc. Stockholders Approve Merger	PU
14-02-03	Cornerstone Therapeutics Inc. Stockholders Approve Merger	MW
14-01-31	Cornerstone Therapeutics Adjourns Special Meeting of Stockholders	MW
13-11-20	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Launches BETHKIS(R) (Tobramycin Inhalation Solution) for Management of Cystic Fibrosis Patients With Pseudomonas Aeruginosa	PU
13-10-31	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics to Host Third Quarter 2013 Conference Call	PU

13-09-16	USA-Les valeurs à suivre à Wall Street (actualisé)
13-09-16	USA-Les valeurs à suivre à Wall Street (actualisé)

Manager	Title	Age	Since
Jon Zwinski CEO	Chief Executive Officer	-	2020-12-31
William James Alexander CTO	Chief Tech/Sci/R&D Officer	76	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	-0.53%	+2.54%	+16.63%	+74.09%	50.03B
OTSUKA HOLDINGS CO., LTD.	-1.81%	-0.49%	+51.99%	+112.44%	36.6B
CIPLA LIMITED	+0.46%	+4.44%	-5.24%	+25.38%	12.47B
ZYDUS LIFESCIENCES LIMITED	+1.05%	+1.63%	+16.19%	+78.22%	11.77B
KRKA, D. D.	-1.33%	-0.76%	+30.08%	+131.70%	9.04B
ONO PHARMACEUTICAL CO., LTD.	-2.99%	-2.09%	+41.02%	-8.36%	7.03B
GEDEON RICHTER	+0.51%	+1.46%	+12.17%	+32.88%	6.79B
THE MEDICINES COMPANY	-.--%	+0.14%	-	-	6.79B
GLENMARK PHARMACEUTICALS LIMITED	+1.99%	+1.91%	+4.68%	+183.54%	6.6B
Average	-0.29%	+1.00%	+20.94%	+78.74%	16.35B
Weighted average by Cap.	-0.62%	+1.27%	+25.18%	+82.84%

Employees

Sector